Table 1

Antibody titre and final diagnosis in the 29 patients with anti-PCNA antibodies

nSexAge (years)PCNADiagnosisFollow-up (years)
1F26>1/1280*SLE with glomerulonephritis (initial diagnosis 5 years earlier)NA
2F691/1280†Scleroderma3.0
3F631/1280Pulmonary sarcoidosis with pulmonary hypertension0.9
4F371/640*SLE with glomerulonephritis (initial diagnosis 4 years earlier)NA
5M631/640Small-cell lung carcinoma0.7
6F441/320Autoimmune thyroiditis3.2
7F421/320Autoimmune thyroiditis0.4
8F441/320Autoimmune thyroiditis, drug-induced neutropenia1.7
9M631/320Polymyalgia rheumatica, drug-induced hepatitis (warfarin)4.7
10M651/320Alcoholic liver cirrhosis (Child’s class C)5.7
11F291/320Unilateral paresthesias0.1
12F631/320Xerostomia1.7
13F591/160Autoimmune thyroiditis0.0
14F711/160Polymyalgia rheumatica4.6
15M681/160Rheumatoid arthritis with secondary amyloidosis0.5
16F561/160Psoriatic arthritis3.1
17M601/160Hepatocellular carcinoma, hepatitis C virus infection2.0
18M771/160Cardiac failure0.6
19F881/160Weakness, diabetes mellitus type 24.6
20M341/80Autoimmune hepatitis2.4
21F671/80Autoimmune thyroiditis0.7
22F501/80Acute rhinoconjunctivitis, follow-up autoimmune thyroiditis0.1
23M361/80Drug-induced hepatitis (turbeculostatic drugs)5.7
24F461/80Rheumatoid arthritis2.8
25M501/80IgA nephropathy4.7
26M411/80Overwhelming pneumonia0.5
27F461/80Osteoarthritis0.0
28M331/80Chronic fatigue syndrome5.2
29F241/80Viral arthritis6.8
  • *No confirmation with dot blot. †Serum also contained anti-centromer antibodies (1/640). NA, not applicable; PCNA, proliferating cell nuclear antigen; SLE, systemic lupus erythematosus.